Sanofi SA is weighing an acquisition of US drugmaker Insmed Inc., people familiar with the matter said, in what would be the largest biopharma deal in years.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
